search
Back to results

Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis

Primary Purpose

Hernia, Inguinal

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Prolene Polypropylene Mesh
Surgisis Inguinal Hernia Matrix
Sponsored by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hernia, Inguinal focused on measuring Hernioplasty, polypropylene, extracellular matrix, xenograft

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Male, adult patients
  • ASA I-III patients
  • Non-complicated primary inguinal hernia (classification according to Gilbert I-II-III-IV-V-VI, modified. according to Rutkow and Robbins) performed in non-emergency setting and repaired with a Lichtenstein's hernioplasty using polypropylene or Surgisis mesh
  • Informed consent

Exclusion Criteria:

  • Recurrent hernias
  • Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient, drug addicted)
  • Hypersensitivity to any drug in study
  • Patients with an intra-operative findings of different pathology will be excluded from the study

Sites / Locations

  • St.Orsola-Malpighi University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

1

2

Arm Description

The Lichtenstein tension-free hernioplasty with polypropylene mesh

The Surgisis mesh group: in this group of patients a 7x20cm Surgisis ES Soft Tissue Graft sheet will be used. In sterile manner the sheet will be removed from the peel-open package. The Surgisis sheet will be cut and fashioned as appropriate. Then the pre-shaped sheet will will be placed for at least 10 minutes into a sterile dish with sterile room-temperature normo-saline to be rehydrated. Using aseptic techique, the rehydrated Surgisis sheet will be transferred to the already prepared and dissected inguinal region and will be fixed with PDS II 2/0.

Outcomes

Primary Outcome Measures

to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), simple verbal scale (SVS) and parenteral/oral analgesic consumption in the two groups

Secondary Outcome Measures

to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS) and simple verbal scale (SVS).
to rate the wound infection risk.
to monitor any other postoperative complication observed in the immediate, mid-term and long-term postoperative period.
to measure the recurrence rate

Full Information

First Posted
January 31, 2008
Last Updated
March 17, 2021
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
search

1. Study Identification

Unique Protocol Identification Number
NCT00614419
Brief Title
Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis
Official Title
Prospective Randomized, Double-blind, Controlled Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis ES Soft Tissue Graft
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
January 2003 (undefined)
Primary Completion Date
December 2003 (Actual)
Study Completion Date
December 2003 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To evaluate the safety and efficacy of the Lichtenstein's hernioplasty using the Surgisis ES soft tissue graft, as a mesh, and to compare it with the traditional Lichtenstein procedure performed with polypropylene mesh.
Detailed Description
Inclusion and Exclusion Criteria Inclusion criteria: Male, adult patients ASA I-III patients Non-complicated primary inguinal hernia (classification according to Gilbert I-II-III-IV-V-VI, modified. according to Rutkow and Robbins) performed in non-emergency setting and repaired with a Lichtenstein's hernioplasty using polypropylene or Surgisis mesh Informed consent Exclusion criteria Recurrent hernias Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient, drug addicted) Hypersensitivity to any drug in study Patients with an intra-operative findings of different pathology will be excluded from the study Outcomes: General objectives of the study will be: to determine the safety of the Lichtenstein's hernioplasty with Surgisis ES by noting any complications observed intraoperatively and postoperatively to determine the efficacy of the Lichtenstein's hernioplasty with Surgisis ES in comparison with the traditional method with polypropylene mesh by noting the grade of postoperative pain, discomfort, quality of life, the rate of wound infection and other complications, and the recurrence rate. The specific objectives of the study will be: to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), simple verbal scale (SVS) and parenteral/oral analgesic consumption in the two groups. to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS) and simple verbal scale (SVS). to measure the postoperative health general status and quality of life with the Short Form 36 (SF-36) questionnaire. to rate the wound infection risk. to monitor any other postoperative complication observed in the immediate, mid-term and long-term postoperative period. to measure the recurrence rate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hernia, Inguinal
Keywords
Hernioplasty, polypropylene, extracellular matrix, xenograft

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
The Lichtenstein tension-free hernioplasty with polypropylene mesh
Arm Title
2
Arm Type
Experimental
Arm Description
The Surgisis mesh group: in this group of patients a 7x20cm Surgisis ES Soft Tissue Graft sheet will be used. In sterile manner the sheet will be removed from the peel-open package. The Surgisis sheet will be cut and fashioned as appropriate. Then the pre-shaped sheet will will be placed for at least 10 minutes into a sterile dish with sterile room-temperature normo-saline to be rehydrated. Using aseptic techique, the rehydrated Surgisis sheet will be transferred to the already prepared and dissected inguinal region and will be fixed with PDS II 2/0.
Intervention Type
Device
Intervention Name(s)
Prolene Polypropylene Mesh
Other Intervention Name(s)
PP
Intervention Description
The Lichtenstein tension-free hernioplasty consists of a swatch of polypropylene mesh, partway slit 1 cm from its inferior edge to accommodate the spermatic cord. The mesh is sutured circumferentially to the internal oblique abdominal muscle, the rectus sheath and the shelving edge of the inguinal ligament. The tails of the mesh are drawn around the cord and the inferior edge of each tail is sutured to the inguinal ligament. In case of direct hernias, no effort is made to repair the hernia itself. In indirect hernias the sac is excised, except for sliding hernias. The polypropylene mesh group: in this group of patients the polypropylene mesh will be fixed by the above mentioned sutures in Prolene 3/0.
Intervention Type
Device
Intervention Name(s)
Surgisis Inguinal Hernia Matrix
Other Intervention Name(s)
SIHM
Intervention Description
The Surgisis mesh group: in this group of patients a 7x20cm Surgisis ES Soft Tissue Graft sheet will be used. In sterile manner the sheet will be removed from the peel-open package. The Surgisis sheet will be cut and fashioned as appropriate. Then the pre-shaped sheet will will be placed for at least 10 minutes into a sterile dish with sterile room-temperature normo-saline to be rehydrated. Using aseptic techique, the rehydrated Surgisis sheet will be transferred to the already prepared and dissected inguinal region and will be fixed with PDS II 2/0.
Primary Outcome Measure Information:
Title
to measure the degree of post-hernioplasty acute and chronic pain with visual analogue scale (VAS), simple verbal scale (SVS) and parenteral/oral analgesic consumption in the two groups
Time Frame
1 week, 1, 3, 6 months, 1, 2, 3, 4, 5 years
Secondary Outcome Measure Information:
Title
to measure the degree of postoperative acute and chronic discomfort with visual analogue scale (VAS) and simple verbal scale (SVS).
Time Frame
3, 6 months, 1, 2, 3, 4, 5 years
Title
to rate the wound infection risk.
Time Frame
1 week, 1, 3, 6 months, 1, 2, 3, 4, 5 years
Title
to monitor any other postoperative complication observed in the immediate, mid-term and long-term postoperative period.
Time Frame
1 week, 1, 3, 6 months, 1, 2, 3, 4, 5 years
Title
to measure the recurrence rate
Time Frame
1 week, 1, 3, 6 months, 1, 2, 3, 4, 5 years

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male, adult patients ASA I-III patients Non-complicated primary inguinal hernia (classification according to Gilbert I-II-III-IV-V-VI, modified. according to Rutkow and Robbins) performed in non-emergency setting and repaired with a Lichtenstein's hernioplasty using polypropylene or Surgisis mesh Informed consent Exclusion Criteria: Recurrent hernias Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient, drug addicted) Hypersensitivity to any drug in study Patients with an intra-operative findings of different pathology will be excluded from the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luca Ansaloni, MD
Organizational Affiliation
St.Orsola-malpighi Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
St.Orsola-Malpighi University Hospital
City
Bologna
ZIP/Postal Code
40138
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis

We'll reach out to this number within 24 hrs